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 Abstract - During surgery, the anaesthetist carefully controls 
the delivery of anaesthesia given to the patient in an effort to 
attain and maintain a consistent and adequate level of anaesthetic 
depth. The aim of this work is to design an internal model control 
(IMC) for anaesthesia depth, and to test it by simulation with 
clinical data. This study uses an internal model control structure 
for the adjustment of Bispectral Index (BIS). Performance of the 
two controllers has been studied for a step change in BIS, 
measured disturbances in the measured variables. In this study 
the simulation shows that the internal model control performed 
better than the PID controller. 
 
 Index Terms – Internal model control, depth of anaesthesia. 
 
I.  INTRODUCTION 
 During surgery the anaesthetist carefully controls the 
delivery of  anaesthesia given to the  patient in an effort to 
attain and maintain a consistent and adequate level of depth of 
anaesthesia, that is, adequate levels of hypnotic, analgesic, and 
paralytic [1]. The anaesthetist is acting as a manual feedback 
controller [2]. The monitoring and control of unconsciousness 
in operating theatre is a major challenge to both anaesthetist 
and machines [3]. 
 Brain monitors like the BIS monitor can now be use to 
measure a patient brain response to anaesthesia this 
information helps clinicians to adjust amount the medication 
given to improve recovery from anaesthesia, also this 
information may help clinicians to reduce the risk of patient 
awareness. In clinical anaesthesia, automatic regulation, in a 
closed-loop control of infusion of drugs has been shown to 
provide more benefits when compared to manual 
administration. A well designed automatic control system can 
avoid both over-dosage and under-dosage of the drugs. 
Closed-loop control minimize the drug consumption, intra-
operative awareness and recovery times, thereby decreasing 
the cost of the surgery and also the cost of the postoperative 
care. Overall, this is to improve the patient’s safety and 
rehabilitation during and after the surgery [4]. 
 The anaesthetist determines any subsequent alteration in 
the anaesthetic level by observing physical signs from the 
patient [5]. These physical signs, the indirect indicators of the 
depth of anaesthesia, may include changes in blood pressures 
or heart rate, lacrimation (the production of tears in the eyes), 
facial grimacing, muscular movements, spontaneous 
breathing, diaphoresis (sweating, especially sweating induced 
for medical reasons), and other signs that may predicate 
awareness [6]. However, they are not reliable indicators of 
changes in patient level of consciousness. Although an 
anaesthetist can adjust recommended anaesthetic dosages 
based on individual patient characteristics, these adjustments 
cannot always account for variability in patient responses to 
anaesthesia or changes in anaesthetic requirements during the 
course of surgery [7]. 
 A major gain of continuous intravenous drug infusion for 
general anaesthesia is the possibility of keeping something 
like constant value of the effect concentration of the drug in 
use [8]. Alson et al. (2008) presents a method for target 
control infusion for neuromuscular blockade level of patients. 
The estimates of the pharmacokinetic /pharmacodynamic 
(PK/PD) model parameters are computed from data collected 
in the first 10 minutes, after a bolus is applied to the patient in 
the induction phase of anaesthesia [9]. 
 Closed loop administration of anaesthetics during surgery 
promises to supply a number of possible benefits, such as, 
minimizing the over all amount of drugs required for each 
person to reduced recovery time and costs, also allowing the 
anaesthetist to focus on more critical safety tasks [10]. 
However, in order to design and impalement feedback controls 
schemes, mathematical model of the patient and drug delivery 
system are required. 
 The proposed Internal Model Control (IMC) uses the 
approximate linear pharmacokinetic-pharmacodynamic (PK– 
PD) model in the controller design, which regulates patient’s 
BIS by manipulating the infusion rate of isoflurane. An 
extensive simulation conducted to investigation the robustness 
of the proposed IMC controller, by considering parameters 
variations in the selected model to account for patient model 
mismatch. The proposed IMC scheme has also been evaluated 
for disturbance rejections. The main contributions of this study 
are to demonstrate the control of hypnosis using IMC, and to 
compare its performance with traditional PID controller. 
 The rest of the paper is presented as follows. Section II 
discusses patient mathematical modeling. The control design 
is introduced in section 3. Simulations and results  are 
presented in section 4. The main outcome are summarizes in 
conclusion section. 
II.  PATIENT MATHEMATICAL MODELS 
 The human body is assumed to be divided into several 
compartments to drive the PK model [11]. A model based on a 
compartmental approach is used. According to this approach, 
the body is assumed to be divided into several compartments. 
In each compartment the drug concentration is homogeneous 
and there are exchanges between compartments. A three 
compartments model is used, in which the main compartment 
represents intravascular blood (blood within arteries and 
veins) and highly irrigated organs (such as heart, brain, liver 
and kidney). The two other compartments represent muscles, 
fat and other organs or tissues. The PK consists of a 3-
compartment model which is shown in Fig. 1, would be 
represented mathematically by the state equations 
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where x ୧ is the amount of drug in the i ୲୦ compartment, k ୧୨ is 
the distribution transfer rate from the i ୲୦compartment to the 
j ୲୦compartment, kଵ଴ is the clearance transfer rate out of the 
central compartment, and I represents the anaesthetic infusion 
rate into the central compartment [12]. 
 
 
Fig. 1 Compartmental model of the patient. 
 
The pharmacodynamics is characterized by a low-pass 
filter related to the central compartment concentration C୮  
in blood: 
ܥ௘ ൌ  ݔሶ௘ ൌ െ݇௘଴ݔ௘ ൅ ݇ଵ௘ݔଵ                                                       ሺ2ሻ 
 
where kୣ଴ and kଵୣ are constants and xୣ is the amount of drug 
in the effect compartment. 
 
ܥሶ௘ ൌ  ݇௘଴ሺܥ௣ െ ܥ௘ሻ                                                                        ሺ3ሻ 
Where ܥ௘ denotes the effect site compartemt concentration. ܥ௣ 
denotes plasma concentration. 
The BIS varaible related to the drug effect concenration ܥ௘ by 
the empirical static non-linear relationship [13], that is called 
Sigmoid Hill Curve: 
  
ܧሺݐሻ ൌ ܧ௢ െ ܧ௠௔௫
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where ܧ  is the measured effect, E଴  represents the baseline 
value (conscious state without propofol), which is typically set 
to 100; E୫ୟ୶ denotes the maximum effect achieved by the 
drug infusion; Cହ଴ is the drug concentration at half maximal 
effect and denotes the patient’s sensitivity to the drug; and γ 
determines the steepness of the static nonlinearity. 
 
III.  THE CONTROL STRUCTURE 
A. Internal Model Control 
  Internal model control relies on the internal model 
control principle, which states that a plant or a process can be 
controlled only if the control system incorporates or 
encapsulates, either implicitly or explicitly, some 
representation of the process [14]. For example in an open 
loop control, the model of the process to be controlled is 
almost exactly known [15]. However, an exact model of the 
plant is not known in almost all practical cases and process-
model mismatch is very common. These uncertainties and un-
modelled dynamics in the system usually affect system 
performance. In such cases IMC is found to be very useful 
[16]. 
 Fig. 2, shows the IMC structure. Here ܩ௣ሺݏሻ א ࣬ሺݏሻ 
 
Fig. 2 Block diagram of IMC. 
 
where ࣬ሺsሻ is the space of all real-rational transfer function, ݎ 
is the input, ݕ is the output and u  is the control input [15]. 
The transfer function from the input  ݎ  to the error ݁ ൌ ݎ െ ݕ 
is given by  
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B. Internal Model Control for Depth of Anaesthesia 
 
 The structure of the IMC in depth of anaesthesia (DoA) is 
depicted in Fig 3. The blocks PK and PD together with the 
nonlinear equation represent the patient’s pharmacokinetics 
and pharmacodynamics, respectively.  Both PK and PD are 
single-input single-output linear time invariant systems. The 
equivalent parallel models for the pharmacokinetics and 
pharmacodynamics are represented by   PK෪  and PD෪  
respectively together with linearization constant K. 
KP~ DP~
PDPK
 
Fig. 3 Block diagram for the DoA control. 
 
The transfer function for the PK in Fig. 3, can be expressed 
by: 
 
ܥ௣ሺݐሻ ൌ ܣ݁ି௣భ௧ ൅ ܤ݁ି௣మ௧ ൅ ܥ݁ି௣య௧  ቂ
ߤ݃
݈݉ቃ                             ሺ7ሻ 
where  C ୮ሺtሻ  is  the  drug  concentration  expressed  in  
microgram  per  milliliter  (propofol), pଵ and  pଶ in the above 
formula would refer to the rate  constant  of the  distribution 
phase  , and    ݌ଷ  is  the  rate  constant  of the  elimination 
phase.   In many  cases,  a  tri-exponential  model  will  
capture  significantly better the  kinetic of the  drug 2 : 
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A   major  advantage  of  exponential  models as in (7) is  that  
they  can  be  easily  derived  using  graphical  means. The  
identification can  be  carried  out  directly by  using either  
bolus  data  and  analyzing the  decaying blood plasma  
characteristic  ,  or  by using  infusion data  and  analyzing 
how  the  plasma  concentration  increases  over  time. 
 
ܲܦሺݏሻ ൌ ௞೐బ௦ା௞೐బ ൅
ఊ
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IV.  SIMULATION AND RESULTS 
 The data from Hospitals are collected into a Matlab 
spreadsheet program. In case of hardcopy form, the data is 
entered manually on the Matlab spreadsheet. These data are 
collected and analysed to establish the relative importance of 
each independent variable in the prediction. The data analysis 
results are integrated for model development. The models are 
developed and designed based on these data analysis and 
initial results presented. Testing is scheduled to the final stage 
of model development. In this study, however, the IMC used 
to generate and provide a much easier framework for design of 
robust control systems. 
The nonlinear DoA model is shown in the block diagram in 
Fig. 4. To perform these simulations, Matlab program is 
developed to compute parameters for both linear and nonlinear 
Simulink models. The Matlab programs is developed to 
evaluate the influence of several parameters (Υ, kୣ଴, and    ܥ௣  ) 
on the nonlinear model. At this point, we assume that 
variability is in both the PK and PD (based on patient’s 
sensitivity to the drug) model parameters. Our control 
simulations showed that the variability in PD parameters have 
more impact on BIS than the variability in PK parameters. 
 This section provides the simulation results of the IMC 
controller for the control of BIS by manipulating Propofol as 
shown in Fig. 5. In Figure 5, the controller regulates the BIS 
by adjusting infusion rate of propofol based on the error 
between set-point and the difference between actual and 
predicted BIS. The IMC performance is considered in this 
work and compared with the PID controller the complete close 
loop system is presented in Fig. 6. 
 
 
 
Fig. 4 Non linear DoA model built in Simulink. 
 
 
 
Fig. 5 Schematic representation of IMC. 
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With the PID controller, the settings were  Kୡ  ൌ െ0.088, τI ൌ  30.476, and τD  ൌ  3.331. 
 
 
Fig. 6 Schematic representation of PID Controller. 
 
The proposed algorithm is simulated using the parameters in 
Table I, for all 12 patient models. 
 
TABLE I 
THE 12 PATIENT PHARMACODYNAMIC MODELS USED IN THIS STUDY 
 
Patient    Age    Length    Weight    Gender     ܥହ଴      ܧ଴           ܧ௠௔௫         ߛ 
1              40       163          54             F            6.33    98.80       94.10     2.24 
2              36       163          50             F            6.76    98.60       86.00     4.29 
3              28       164          52             F            8.44    91.20       80.70     4.1 
4              50       163          83             F            6.44    95.90       102.00   2.18 
5              28       164          60             M           4.93    94.70       85.30     2.46 
6              43       163          59             F           12.10   90.20       147.00   2.42 
7              37       187          75             M           8.02    92.00       104.00   2.10 
8              38       174          80             F            6.56    95.50       76.40     4.12 
9              41       170          70             F            6.15    89.20       63.80     6.89 
10            37       167          58             F           13.70   83.10       151.00   1.65 
11            42       179          78             M          4.82     91.80       77.90     1.85 
12            34       172          58             F           4.95     96.20       90.80     1.84 
 
Changes in volumes of the compartments (Vଵ, Vଶ, and Vଷ) 
has very small effect on the performance. In the PD 
parameters, higher ECହ଴ሺ3.7ሻ  indicates the need for further 
drug to get the same DoA level, higher Υሺ3.21ሻ  represents 
higher nonlinearity and lower kୣ଴  (0.2388) indicates 
sluggishness in response. For the sensitive patient kଵ଴,kଵଶ, and kଵଷ  are low (0.089, 0.084, and 0.031, respectively) 
and kଶଵ, kଷଵ, are high (0.0691, and 0.0039, respectively). In the 
PD parameters, lower ECହ଴ሺ1.6ሻ  indicates the need of a 
smaller amount drug to get the same DoA level, lower Υሺ2ሻ 
represents lower nonlinearity, and higher kୣ଴ሺ0.459ሻ indicates 
more rapidly response. Also, since kୣ଴ represents the process 
gain, higher kୣ଴  (higher gain) represents faster response and 
lower kୣ଴  (lower gain) represents slower response of the 
process. To come to the point, two parameters ሺλ, nሻ for IMC, 
and three parameters ሺ Kୡ, τI, τDሻ  for PID are used for 
modifying the controller. 
 
 
Fig. 7 BIS vs time for the IMC.  
 
Fig. 8 BIS vs time for the PID.  
 
Fig. 9 Propofol infusion rate in IMC. 
zeros(s)
(s+0.00778)(s+0.000424)(s+0.0000352)
PK Model
In1 Out1
PID Control ler
ke0
s+ke0
PD Model
c yfun
Embedded
MATLAB Function
BIS Reference
BIS
20 40 60 80 100 120 140 160 180 200
0
10
20
30
40
50
60
70
80
90
100
time (s)
BI
S
0 2000 4000 6000 8000 10000 12000
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Time  (s)
Pr
op
of
o
l [u
g/
m
l]
0 2000 4000 6000 8000 10000 12000
40
50
60
70
80
90
100
Time (s)
BI
S
  
Fig. 10 Propofol infusion rate in PID controller.  
 
 
V.  CONCLUSIONS 
 In this paper, an internal model control, for regulation of 
anaesthesia using BIS as the controlled variable have been 
developed and evaluated thoroughly. The performance of this 
controller is considered along with the performance of the 
traditional PID controller. In comparison with traditional PID 
controller, the proposed internal model control  is  found to be 
robust to intra- and inter-patient variability, and better at 
handling disturbances and measurement noise. In system 
performance, the settling time has been shortened (؆4.5 min) 
and the performance with no undershoot in the IMC, also 
undershoot was higher with PID controller.  The performance 
of the IMC controller is found to perform the best and hence 
recommended for DoA control. The proposed IMC strategy 
was also found to be more robust to intra- and inter-patient 
variability.  
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